| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10967570 | Vaccine | 2013 | 7 Pages |
Abstract
Conclusion: PCV13 has a favorable safety profile similar to that of PCV7, a vaccine for which there is >10 years clinical experience.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Allison Thompson, Alejandra Gurtman, Scott Patterson, Christine Juergens, France Laudat, Emilio A. Emini, William C. Gruber, Daniel A. Scott,